Figures computed from official regulatory filings — .
Ownershipinsiders 0% · institutions 23.52%
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for abrdn Healthcare Investors only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
43 buys— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Mahai Chris LaVictoire | Buy | $10.5K | conv 61First in 12mo |
| SEC |
| DiMartino Rosetrack record | Buy | $18.9K | conv 50First in 12mo | SEC |
| Goetz Kathleentrack record | Buy | $8.6K | conv 60First in 12mo | SEC |
| Goodson Alan R | Buy | $2.7K | conv 68First in 12mo | SEC |
| Reit Toddtrack record | Buy | $16.9K | conv 54Cluster | SEC |
| Maher Billtrack record | Buy | $16.6K | conv 34 | SEC |
| OMSTEAD DANIEL Rtrack record | Buy | $148.5K | conv 47Unusual size | SEC |
| OMSTEAD DANIEL Rtrack record | Buy | $150.9K | conv 65Unusual sizeFirst in 12mo | SEC |
| Goetz Kathleentrack record | Buy | $1.5K | conv 24Unusual size | SEC |
| Goetz Kathleentrack record | Buy | $10.4K | conv 48First in 12mo | SEC |
| OMSTEAD DANIEL Rtrack record | Buy | $106.8K | conv 20 | SEC |
| OMSTEAD DANIEL Rtrack record | Buy | $104.4K | conv 25 | SEC |
| Bailey Jeffrey Allentrack record | Buy | $10K | conv 17 | SEC |
| OMSTEAD DANIEL Rtrack record | Buy | $105.1K | conv 22 | SEC |
| OMSTEAD DANIEL Rtrack record | Buy | $110.4K | conv 44First in 12mo | SEC |
| OMSTEAD DANIEL Rtrack record | Buy | $108K | conv 34 | SEC |
| OMSTEAD DANIEL Rtrack record | Buy | $112.4K | conv 32 | SEC |
| OMSTEAD DANIEL Rtrack record | Buy | $84.5K | conv 26 | SEC |
| Kent Thomas M | Buy | $26.6K | conv 36First in 12mo | SEC |
| Gasperoni Timothy L | Buy | $25K | conv 23First in 12mo | SEC |
| STEBBINS LUCINDA Htrack record | Buy | $71.5K | conv 59Unusual size | SEC |
| REINHARDT UWE Etrack record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| REINHARDT UWE Etrack record | Other | $18.7K | SEC |
| OMSTEAD DANIEL Rtrack record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| OMSTEAD DANIEL Rtrack record | Other | $299.1K | SEC |